FDA Investigator Lakshmi Narasimhan, PhD
Lakshmi Narasimhan, PhD has conducted inspections on 9 sites in 3 countries as of 07 May 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
07 May 2018
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
India,
Ireland
FDA Investigators that have inspected at least one site in common with Lakshmi Narasimhan, PhD:
Abdur Razzaque,
Adetutu M Gidado,
Aditi S Thakur,
Anastasia M Shields,
Andrew J Barrowcliff,
Anita R Michael,
Ann Marie Montemurro,
Anne E Johnson,
Arsen Karapetyan,
Arulvathani P Arudchandran,
Benjamin J Smith,
Bijoy Panicker,
Bo Chi, PhD,
Brooke K Higgins,
Brooke K Seeman,
Candace Y Gomez Broughton,
Carl A Huffman, III,
Charisse K Green,
Christopher T Peters,
Colleen Thomas, PhD,
Concepcion Cruz, Jr,
Daniel J Roberts,
Dennis Cantellops Paite,
Diane L Raccasi,
Douglas A Campbell,
Dr. Barbara D Paul, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Dr. Willie Wilson, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Eileen A Liu,
Emest F Bizjak,
Erin D Mccaffery,
Francis A Guidry,
Gayle S Lawson,
Geneve M Maxwell,
Geneve M Parks,
Guerlain Ulysse,
Gwyn G Dickinson,
Hala L Selby,
Howard Anderson, PhD,
Hyung Yul Lee,
J Paul Kirwan, PhD,
Jacqueline Mdiaz Albertini,
Javier E Santos,
Jay T Wong,
Jazmine N Still,
Jeanne Fringer, PhD,
Jeffrey A Sommers,
Jeffrey D Meng,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jens Fricke,
Jing Fang,
Joel D Martinez,
Jose Velez,
Juan A Morales,
Julianne C Mccullough,
Junho Pak,
Justin A Boyd,
Kalavati Suvarna, PhD,
Kendra L Brooks,
Kristen Nickens, PhD,
Kshitij A Patkar,
Lance Mde Souza, MBA,
Larry K Austin,
Laura Fontan, MS,
Laurie Nelson,
LCDR Chad N Thompson,
Leslie Arivera Rosado, PhD,
Linda F Murphy,
Lindsey Brown, PhD,
Lisa L Flores,
Margaret E Sarles,
Maria Cecilia Tami, PhD,
Maria Estrella,
Maria Gutierrez Hoffman, PhD,
Maria Gutierrez Lugo, PhD,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Mariza M Jafary,
Massod Rahimi, PhD,
Maxwell Van Tassell, PhD,
Meisha R Sampson,
Meisha Waters,
Melissa J Garcia,
Merry Christie, PhD,
Michael A Charles,
Michael G Truchan,
Michael Shanks, MS,
Michele L Forster, PhD,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Mindy M Chou,
Mra Davism,
Muna Algharibeh,
Muralidhara B Gavini, PhD,
Ogechi C Nna,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Paul Mouris,
Paula A Trost,
Paula M Laplant,
Prabhu P Raju,
Rajiv R Srivastava,
Rebecca E Dombrowski,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Robert J Martin,
Robert M Barbosa,
S Lori Brown, PhD MPH,
Sandra A Hughes,
Sarah Kennett, PhD,
Sharon K Thoma, PharmD,
Shirley J Berryman,
Sony Mathews,
Steven E Bowen, PhD,
Steven P Donald,
Thomas E Friel,
Thuy T Nguyen, LCDR,
Tzanko Stantchev,
Vlada Matusovsky,
Wayne E Seifert,
Xiaokuang Lai, PhD,
Xu Michael Di, PhD,
Yun Wu, PhD,
Zhenzhen Liu, PhD,
Zhong Li, PhD
Lakshmi Narasimhan, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| May, 2011 | FDA 483 | Regeneron Pharmaceuticals, Inc. - Form 483, 2011-05-20 |
| July, 2015 | FDA 483 | Intas Pharmaceuticals Limited - Form 483, 2015-07-03 |
| March, 2016 | FDA 483 | Steriscience Specialties Private Limited - Form 483, 2016-03-16 |
| April, 2013 | FDA 483 | Exelead, Inc. - Form 483, 2013-04-19 |
| May, 2018 | FDA 483 | Exelead, Inc. - Form 483, 2018-05-15 |
| April, 2017 | FDA 483 | Biocon Biologics Limited - Form 483, 2017-04-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more